ABSTRACT
Cytotoxic lymphocytes (CLs) induce caspase activation and apoptosis of target cells either through Fas activation or through release of granule cytotoxins, particularly granzyme B. CLs themselves resist granule-mediated apoptosis but are eventually cleared via Fas-mediated apoptosis. Here we show that the CL cytoplasmic serpin proteinase inhibitor 9 (PI-9) can protect transfected cells against apoptosis induced by either purified granzyme B and perforin or intact CLs. A PI-9 P1 mutant (Glu to Asp) is a 100-fold-less-efficient granzyme B inhibitor that no longer protects against granzyme B-mediated apoptosis. PI-9 is highly specific for granzyme B because it does not inhibit eight of the nine caspases tested or protect transfected cells against Fas-mediated apoptosis. In contrast, the P1(Asp) mutant is an effective caspase inhibitor that protects against Fas-mediated apoptosis. We propose that PI-9 shields CLs specifically against misdirected granzyme B to prevent autolysis or fratricide, but it does not interfere with homeostatic deletion via Fas-mediated apoptosis.
ACKNOWLEDGMENTS
C.H.B., V.R.S., and J.S. contributed equally to this work.
This work was supported by the National Health and Medical Research Council of Australia, Monash University, and the Anti-Cancer Council of Victoria.
We are grateful to D. Pickup (Duke University) for providing the CrmA cDNA, R. Sutherland (Garvan Institute) for the MCF-7 cells, and A. Strasser (Walter and Eliza Hall Institute) for discussions. We thank L. McDonald for technical assistance and F. Scott and M. Chu for help with preparation of figures.